SCNI

Scinai Immunotherapeutics
SCNI

Overview Fund Trends Analyst Outlook Journalist POV

11 hedge funds and large institutions have $2.51M invested in Scinai Immunotherapeutics in 2018 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
11
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$22.4K
2
+$17.9K

Top Sellers

1
-$23.1K
2
-$9.51K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$2.01M
2
$141K
3
$140K
4
$94K
5
$61K
6
$25K
7
$15K
8
$14K
9
$5K
10
$5K
11
$3K